Haidy Carrasquillo Rodriguez
General Practice · Sanford, FLNPI 1639119340
Payments from drug & device makers
Across 130 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$292
- Lilly USA, LLC$286
- Amgen$250
- Amarin Pharma, Inc.$231
- Bayer$222
- GSK$215
- plus $1K from 11 others
What the payments were for
- Food & beverage$2,771100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $292 |
| Lilly USA, LLC | 10 | $286 |
| Amgen | 13 | $250 |
| Amarin Pharma, Inc. | 11 | $231 |
| Bayer | 12 | $222 |
| GSK | 14 | $215 |
| Medicomp Inc | 1 | $198 |
| Boehringer Ingelheim | 10 | $193 |
| Exact Sciences | 9 | $166 |
| AbbVie | 8 | $148 |
| Novo Nordisk | 6 | $122 |
| Novartis | 7 | $118 |
| Abbott | 6 | $110 |
| Pfizer | 5 | $66 |
| Emergent Biosolutions Inc. | 1 | $57 |
| Phadia US Inc. | 3 | $48 |
| AstraZeneca | 3 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,771 in reported general payments places this provider in the 90th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 134 | $105,370 |
| TradjentaLinagliptin | 128 | $105,289 |
| TrulicityDulaglutide | 55 | $98,743 |
| EliquisApixaban | 87 | $98,219 |
| Enbrel MiniEtanercept | 12 | $88,134 |
| OtezlaApremilast | 11 | $52,911 |
| KerendiaFinerenone | 39 | $50,618 |
| JardianceEmpagliflozin | 40 | $45,611 |
| JanuviaSitagliptin Phosphate | 27 | $33,848 |
| LinzessLinaclotide | 35 | $27,007 |
| XareltoRivaroxaban | 24 | $25,006 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $23,814 |
| MounjaroTirzepatide | 18 | $23,222 |
| EntrestoSacubitril/Valsartan | 13 | $15,374 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 103 | $15,357 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance | $193 | $150,900168 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $286 | $121,96573 claims |
| AstraZenecaFarxiga | $47 | $105,370134 claims |
| PfizerEliquis | $66 | $98,21987 claims |
| AmgenOtezla | $250 | $52,91111 claims |
| BayerKerendia | $222 | $50,61839 claims |
| AbbVieLinzess, Synthroid | $148 | $30,34082 claims |
| Johnson & JohnsonXarelto | $292 | $25,00624 claims |
| GSKTrelegy Ellipta | $215 | $23,81421 claims |
| NovartisEntresto | $118 | $15,37413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,901 general practice providers in Florida.
Other general practice in Sanford
- Jose CardonaMiami$71M
- Lawrence GalitzMiami Gardens$42.5M
- Armando AcevedoMiami$15.2M
- Jorge AmayaMiami$14.2M
- Frank AlvarezHialeah$13.6M
- Hector RodriguezMiami$12.8M
- Eddie ArmasSouth Miami$12.4M
- Idalia AcostaMiami$11.4M
- Lilia Rodriguez AblesMiami$10.7M
- Jorge Monroy AvellaOcoee$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.